BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 25679489)

  • 1. Surface engineered and ligand anchored nanobioconjugate: an effective therapeutic approach for oral insulin delivery in experimental diabetic rats.
    Sharma R; Gupta U; Garg NK; Tyagi RK; Jain NK
    Colloids Surf B Biointerfaces; 2015 Mar; 127():172-81. PubMed ID: 25679489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation Of Vitamin B
    Long L; Lai M; Mao X; Luo J; Yuan X; Zhang LM; Ke Z; Yang L; Deng DY
    Int J Nanomedicine; 2019; 14():7743-7758. PubMed ID: 31571874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HP55-coated capsule containing PLGA/RS nanoparticles for oral delivery of insulin.
    Wu ZM; Zhou L; Guo XD; Jiang W; Ling L; Qian Y; Luo KQ; Zhang LJ
    Int J Pharm; 2012 Apr; 425(1-2):1-8. PubMed ID: 22248666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro uptake evaluation in Caco-2 cells and in vivo results in diabetic rats of insulin-loaded PLGA nanoparticles.
    Reix N; Parat A; Seyfritz E; Van der Werf R; Epure V; Ebel N; Danicher L; Marchioni E; Jeandidier N; Pinget M; Frère Y; Sigrist S
    Int J Pharm; 2012 Nov; 437(1-2):213-20. PubMed ID: 22940208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folate-decorated PLGA nanoparticles as a rationally designed vehicle for the oral delivery of insulin.
    Jain S; Rathi VV; Jain AK; Das M; Godugu C
    Nanomedicine (Lond); 2012 Sep; 7(9):1311-37. PubMed ID: 22583576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation of insulin loaded PLGA-Hp55 nanoparticles for oral delivery.
    Cui FD; Tao AJ; Cun DM; Zhang LQ; Shi K
    J Pharm Sci; 2007 Feb; 96(2):421-7. PubMed ID: 17051590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multifunctional Composite Microcapsules for Oral Delivery of Insulin.
    Sun S; Liang N; Gong X; An W; Kawashima Y; Cui F; Yan P
    Int J Mol Sci; 2016 Dec; 18(1):. PubMed ID: 28036045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VB12-coated Gel-Core-SLN containing insulin: Another way to improve oral absorption.
    He H; Wang P; Cai C; Yang R; Tang X
    Int J Pharm; 2015 Sep; 493(1-2):451-9. PubMed ID: 26253378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioinspired butyrate-functionalized nanovehicles for targeted oral delivery of biomacromolecular drugs.
    Wu L; Liu M; Shan W; Zhu X; Li L; Zhang Z; Huang Y
    J Control Release; 2017 Sep; 262():273-283. PubMed ID: 28774842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enteric-coated capsules filled with mono-disperse micro-particles containing PLGA-lipid-PEG nanoparticles for oral delivery of insulin.
    Yu F; Li Y; Liu CS; Chen Q; Wang GH; Guo W; Wu XE; Li DH; Wu WD; Chen XD
    Int J Pharm; 2015 Apr; 484(1-2):181-91. PubMed ID: 25724135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polyglutamic Acid Functionalization of Chitosan Nanoparticles Enhances the Therapeutic Efficacy of Insulin Following Oral Administration.
    Urimi D; Agrawal AK; Kushwah V; Jain S
    AAPS PharmSciTech; 2019 Feb; 20(3):131. PubMed ID: 30815757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antacid co-encapsulated polyester nanoparticles for peroral delivery of insulin: development, pharmacokinetics, biodistribution and pharmacodynamics.
    Sharma G; van der Walle CF; Ravi Kumar MN
    Int J Pharm; 2013 Jan; 440(1):99-110. PubMed ID: 22227604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and in vivo evaluation of insulin-loaded biodegradable nanoparticles prepared from diblock copolymers of PLGA and PEG.
    Haggag Y; Abdel-Wahab Y; Ojo O; Osman M; El-Gizawy S; El-Tanani M; Faheem A; McCarron P
    Int J Pharm; 2016 Feb; 499(1-2):236-246. PubMed ID: 26746800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thiol functionalized polymethacrylic acid-based hydrogel microparticles for oral insulin delivery.
    Sajeesh S; Vauthier C; Gueutin C; Ponchel G; Sharma CP
    Acta Biomater; 2010 Aug; 6(8):3072-80. PubMed ID: 20144748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Galactosylated PLGA nanoparticles for the oral delivery of resveratrol: enhanced bioavailability and in vitro anti-inflammatory activity.
    Siu FY; Ye S; Lin H; Li S
    Int J Nanomedicine; 2018; 13():4133-4144. PubMed ID: 30038494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intestinal mucosa permeability following oral insulin delivery using core shell corona nanolipoparticles.
    Li X; Guo S; Zhu C; Zhu Q; Gan Y; Rantanen J; Rahbek UL; Hovgaard L; Yang M
    Biomaterials; 2013 Dec; 34(37):9678-87. PubMed ID: 24016855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-S.O (sodium oleate) complex-loaded PLGA nanoparticles: formulation, characterization and in vivo evaluation.
    Sun S; Liang N; Piao H; Yamamoto H; Kawashima Y; Cui F
    J Microencapsul; 2010; 27(6):471-8. PubMed ID: 20113168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation, characterization, and evaluation in vivo of Ins-SiO₂-HP55 (insulin-loaded silica coating HP55) for oral delivery of insulin.
    Zhao X; Shan C; Zu Y; Zhang Y; Wang W; Wang K; Sui X; Li R
    Int J Pharm; 2013 Sep; 454(1):278-84. PubMed ID: 23830939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel ligand conjugated nanoparticles for oral insulin delivery.
    Liu C; Shan W; Liu M; Zhu X; Xu J; Xu Y; Huang Y
    Drug Deliv; 2016 Jul; 23(6):2015-25. PubMed ID: 26203690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protease inhibition and absorption enhancement by functional nanoparticles for effective oral insulin delivery.
    Su FY; Lin KJ; Sonaje K; Wey SP; Yen TC; Ho YC; Panda N; Chuang EY; Maiti B; Sung HW
    Biomaterials; 2012 Mar; 33(9):2801-11. PubMed ID: 22243802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.